 | Up a level |
Number of items: 1.
Cora, N. S., Sergio, B., Ugo, D. G., Giuseppe, P., Simon, C., Wassim, A., Angel, A. A. Jose, Gedske, D., Karim, F., Eliahu, G., Axel, H., Florence, J., Ray, M., Axel, S. M., Maria, P. Josep, Brieuc, S., Srikala, S., Tony, G., Charles, J. R. and Howard, I. S. (2017). The TRITON clinical trial programme: evaluation of the PARP inhibitor rucaparib in patients with metastatic castration-resistant prostate cancer (mCRPC) associated with homologous recombination deficiency (HRD). Ann. Oncol., 28. OXFORD: OXFORD UNIV PRESS. ISSN 1569-8041